SLC2A4 and breast cancer: SLC2A4 encodes a protein that functions as an insulin-regulated facilitative glucose transporter; inhibition of this gene affects cell proliferation and cell viability, suggesting a potential biological hypothesis for how ACAP1 may be involved with breast cancer [34].